ISSN : -
E-ISSN : 2146-3131

Impact Factor
Slider 1
Slider 3
Slider 4
Slider 5
Slider 6

News See All

Following its historic entry into the Q2 quartile in 2022, Balkan Medical Journal has now achieved Q1 ranking in 2024, making it the first Turkish medical journal to reach this top-tier distinction. With a notable Impact Factor of 3.8, this elevation underscores the journal’s commitment to excellence and its growing global influence in the field of medical research
We are pleased to announce that, according to the 2024 Scopus data, Balkan Medical Journal has achieved a CiteScore of 3.7. This reflects the journal’s continued commitment to publishing high-quality, impactful research in the field of general medicine.  
We are pleased to report that our journal has achieved an Impact Factor of 1.9 for the year 2023.  
Balkan Medical Journal adopts the WAME recommendations on ChatGPT and Chatbots related to scientific publications http://www.balkanmedicaljournal.org/static.php?id=10  
In the field of computer science, known as artificial intelligence, algorithms imitate reasoning tasks that are typically performed by humans. The techniques that allow machines to learn and get better at tasks such as recognition and prediction, which form the basis of clinical practice, are referred to as machine learning, which is a subfield of artificial intelligence. http://balkanmedicaljournal.org/uploads/pdf/pdf_BMJ_2461.pdf
Type 1 interferonopathy is a novel context reflecting a group of inborn disorders sharing common pathway disturbances. This group of diseases is characterized by autoimmunity and autoinflammation caused by an upregulation of type 1 interferons (IFN)s due to certain genetic mutations. http://balkanmedicaljournal.org/uploads/pdf/pdf_BMJ_2501.pdf

Articles See All

Mirac Ajredini, Arman Erkan, Amishi Desai, et al.
This study by Ajredini et al. synthesizes contemporary evidence on the transabdominal surgical management of ileal pouch failure, with a focus on standardized preoperative evaluation, unified nomenclature, the Remzi classification for reoperative pouch surgery, and the role of multidisciplinary care in specialized high-volume centers.
Rongxing Qin, Hongyu Xu, Qingchun Qin, et al.
This study by Qin et al. integrates single-cell RNA sequencing, spatial transcriptomics, and molecular docking analyses to delineate cellular heterogeneity and intercellular communication in carotid atherosclerosis, and to identify cannabidiol-related molecular targets with potential therapeutic relevance.
Chongze Lin, Sisi Shao, Qianjia Wu, et al.
In this study, Lin et al. analyzed NHANES 1999–2018 data to evaluate the impact of social determinants of health on all-cause and cardiovascular mortality among U.S. adults with hyperuricemia and/or gout, showing that cumulative social disadvantage is an independent predictor of mortality, particularly in individuals under 60 years of age.
Zehra Manav Yiğit, Aydan Mengübaş Erbaş, Ayberk Türkyılmaz, et al.
This study by Manav Yiğit et al. characterizes the molecular and clinical spectrum of Wiedemann–Steiner syndrome in the largest Turkish cohort to date, identifying nine novel KMT2A variants and highlighting expanded neurodevelopmental, endocrine, and systemic features without significant genotype–phenotype correlations.
Erjie Xie, Yuedi Tang
This study by Xie and Tang investigates whether the severity and longitudinal trajectories of depressive symptoms are associated with the risk of hearing loss among adults aged 55 years and older.

Image Corner

FIG. 1. Representative clinical photographs and chest CT images demonstrating findings before and after secukinumab therapy, showing regression of psoriatic skin lesions and post-treatment pulmonary changes on high-resolution CT.

News from Balkan Medical Journal See All

Balkan Medical Journal continues its scientific journey in the Q1 quartile, as reported by Journal Citation Reports (Clarivate). Indexed in Science Citation Index Expanded (SCIE), the journal remains committed to excellence in medical research.
Starting in 2026, the Balkan Medical Journal will adopt a monthly (12 issues/year) and online-only publication model. This update aims to enhance publication efficiency, increase accessibility, and support faster dissemination of scientific content.